PubRank

Vicky Goh

Author PubWeight™ 48.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 2012 2.31
2 Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy? J Nucl Med 2012 2.14
3 Pelvic MRI for guiding treatment decisions in rectal cancer. Oncology (Williston Park) 2014 2.07
4 Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. Radiology 2012 2.00
5 Optimizing colonic distention for multi-detector row CT colonography: effect of hyoscine butylbromide and rectal balloon catheter. Radiology 2003 1.96
6 Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res 2013 1.92
7 Lung cancer perfusion at multi-detector row CT: reproducibility of whole tumor quantitative measurements. Radiology 2006 1.91
8 Leukocyte DNA damage after multi-detector row CT: a quantitative biomarker of low-level radiation exposure. Radiology 2007 1.82
9 CT response assessment combining reduction in both size and arterial phase density correlates with time to progression in metastatic renal cancer patients treated with targeted therapies. Cancer Biol Ther 2010 1.80
10 Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study. Lancet Oncol 2007 1.76
11 Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis. Eur J Nucl Med Mol Imaging 2012 1.75
12 Polyp detection with CT colonography: primary 3D endoluminal analysis versus primary 2D transverse analysis with computer-assisted reader software. Radiology 2006 1.50
13 Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology 2012 1.46
14 Quantitative assessment of lung cancer perfusion using MDCT: does measurement reproducibility improve with greater tumor volume coverage? AJR Am J Roentgenol 2006 1.19
15 Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer. Eur Radiol 2014 1.05
16 Tumor antivascular effects of radiotherapy combined with combretastatin a4 phosphate in human non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007 1.04
17 Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis? Eur J Radiol 2012 1.03
18 Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy. Radiology 2013 0.96
19 Changes in primary breast cancer heterogeneity may augment midtreatment MR imaging assessment of response to neoadjuvant chemotherapy. Radiology 2014 0.95
20 Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: In vivo whole tumor assessment using volumetric perfusion computed tomography. Int J Radiat Oncol Biol Phys 2007 0.95
21 The role of functional imaging in colorectal cancer. AJR Am J Roentgenol 2010 0.93
22 The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging. Semin Ultrasound CT MR 2013 0.90
23 Reproducibility of 2D and 3D fractal analysis techniques for the assessment of spatial heterogeneity of regional blood flow in rectal cancer. Radiology 2012 0.90
24 Angiogenesis in non-small cell lung cancer: imaging with perfusion computed tomography. J Thorac Imaging 2010 0.88
25 The association of 18F-FDG PET/CT parameters with survival in malignant pleural mesothelioma. Eur J Nucl Med Mol Imaging 2013 0.85
26 Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome. Insights Imaging 2015 0.84
27 Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia. Radiology 2012 0.84
28 The precision of textural analysis in (18)F-FDG-PET scans of oesophageal cancer. Eur Radiol 2015 0.84
29 Perfusion CT assessment of the colon and rectum: feasibility of quantification of bowel wall perfusion and vascularization. Eur J Radiol 2011 0.84
30 Functional imaging of colorectal cancer: positron emission tomography, magnetic resonance imaging, and computed tomography. Clin Colorectal Cancer 2009 0.83
31 Primary colorectal cancer: use of kinetic modeling of dynamic contrast-enhanced CT data to predict clinical outcome. Radiology 2013 0.81
32 Predicting response to neoadjuvant chemotherapy in primary breast cancer using volumetric helical perfusion computed tomography: a preliminary study. Eur Radiol 2012 0.81
33 Quantitative helical dynamic contrast enhanced computed tomography assessment of the spatial variation in whole tumour blood volume with radiotherapy in lung cancer. Lung Cancer 2009 0.80
34 Reproducibility of dynamic contrast-enhanced MR imaging: why we should care. Radiology 2013 0.79
35 Hidradenitis suppurativa: MRI features in anogenital disease. Dis Colon Rectum 2014 0.79
36 Diffusion tensor imaging (DTI) of desmoid tumours in familial adenomatous polyposis: initial experience. Eur J Radiol 2011 0.78
37 Imaging breast cancer response during neoadjuvant systemic therapy. Expert Rev Anticancer Ther 2005 0.78
38 Functional computed tomography imaging. Invest Radiol 2012 0.77
39 CT coronary angiography: quantitative assessment of myocardial perfusion using test bolus data-initial experience. Eur Radiol 2008 0.77
40 Molecular and Functional Imaging of Bone Metastases in Breast and Prostate Cancers: An Overview. Clin Nucl Med 2016 0.76
41 Molecular imaging of hypoxia in non-small-cell lung cancer. Eur J Nucl Med Mol Imaging 2015 0.75
42 Quality control within the multicentre perfusion CT study of primary colorectal cancer (PROSPeCT): results of an iodine density phantom study. Eur Radiol 2014 0.75
43 Water-fat separation in diffusion-weighted EPI using an IDEAL approach with image navigator. Magn Reson Med 2014 0.75
44 Bone metastases in prostate cancer: which scan? BJU Int 2014 0.75
45 Functional imaging of the bowel. Abdom Imaging 2013 0.75
46 Automatic region-of-interest segmentation and registration of dynamic contrast-enhanced images of colorectal tumors. Phys Med Biol 2014 0.75
47 Imaging Tumor Response and Tumoral Heterogeneity in Non-Small Cell Lung Cancer Treated With Antiangiogenic Therapy: Comparison of the Prognostic Ability of RECIST 1.1, an Alternate Method (Crabb), and Image Heterogeneity Analysis. J Thorac Imaging 2015 0.75
48 Functional imaging of colorectal cancer: positron emission tomography, magnetic resonance imaging, and computed tomography. Clin Colorectal Cancer 2009 0.75